搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
Survival Of The Fittest: How Much AI Do You Trade?
AI stocks like Nvidia have outperformed the market. Click here to learn strategies to manage risk and enhance portfolio ...
5 天
Studies show immunotherapy improves long-term survival in growing number of cancers
Immunotherapy, which works by enabling the body's immune system to recognize and destroy cancer cells improves long-term ...
HealthDay on MSN
2 天
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...
HealthDay on MSN
1 天
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk ...
Medpage Today on MSN
4 天
Survival Win for Pembrolizumab in Early Triple-Negative Breast Cancer
Notably, patients benefited from pembrolizumab regardless of whether they achieved a pathologic complete response (pCR), ...
1 天
Does sacking a manager while in relegation zone improve Premier League survival hopes?
No Premier League manager departures so far this season; only 42 per cent of teams retain top-flight status after axing ...
Medscape
4 天
Pembrolizumab Plus Chemoradiotherapy Provides Significant Survival Benefit in Cervical Cancer
Patients with locally advanced cervical cancer were randomized to receive either pembrolizumab or placebo in combination with ...
Too Old to Operate
11 天
Higher Donor−Recipient BMI Ratio Increases Mortality Risk in Heart Transplants
The following is a summary of “Impact of Donor−Recipient BMI Ratio on Survival Outcomes of Heart Transplant Recipients: A ...
Too Old to Operate
2 天
Sustained Survival Advantage of Nivolumab Plus Ipilimumab in Advanced Melanoma
The following is a summary of “Final, 10-Year outcomes with Nivolumab plus Ipilimumab in advanced melanoma,” published in the September 2024 issue of Dermatology by Wolchok et al. Researchers ...
The American Journal of Managed Care
13 小时
Pan-Immune-Inflammation–Based Nomogram Predicts OS, PFS in Epithelial Ovarian Cancer
Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...
Medscape
5 天
Socioeconomic and Molecular Factors Contribute to Racial Disparities in Colorectal Cancer ...
Researchers conducted a single-center cohort study of more than 47,000 patients diagnosed with CRC from January 1, 1973, to ...
emjreviews.com
6 天
Pembrolizumab with Chemoradiotherapy Improves Cervical Cancer Survival: ESMO 2024
Discover the results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study, presented at ESMO 2024, Barcelona, Spain ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈